TLR4 and prostate carcinoma: Recent reports have revealed that lipids could promote CRC progression by upregulating β2-adrenergic receptor and toll-like receptor 4 (TLR4) expression [48, 49] and could activate the STAT3 signaling pathway in prostate cancer as a signal transduction mediator [50].